ÍøºìºÚÁÏ

Skip to main content

R. David Anderson, MD, MS, FACC, FACC, FSCAI, FSCAI

Cardiologist (Heart Specialist), Interventional Cardiologist, Internist

Photo of R. David Anderson

Research at a glance

Top areas of exploration

  • Myocardial Infarction , 22 publications
  • Myocardial Ischemia , 15 publications
  • Coronary Artery Disease , 14 publications
  • Coronary Circulation , 10 publications

Research activity

115 publications

7,441 citations

Why is this important?

Active clinical trials

CardiALLO-HF
Investigator
R. David Anderson
Status
Accepting Candidates
PROTECT IV

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - 90 Years
Sexes
All
SMART

The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

115 publications

2015

Are We There Yet?: Should All Comatose Cardiac Arrest Survivors Go to the Cath Lab?

JACC. Cardiovascular interventions

•

2015

Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.

European heart journal

•

2015

Cognitive-Motivational Influences On ÍøºìºÚÁÏ Behavior Change in Chronic Pain

Journal of Pain

2015

Long-term use of ticagrelor in patients with prior myocardial infarction.

The New England journal of medicine

•

2015

Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Study.

Cardiovascular endocrinology